VBI Vaccines, based in Cambridge, MA, is a biopharmaceutical company focused on developing innovative vaccines and immunotherapies to address infectious diseases and cancer. With a strong emphasis on stimulating and fortifying the immune system, VBI is dedicated to overcoming public health challenges and improving overall health for all individuals.
Utilizing their expertise in immunology and vaccinology, VBI's pipeline of vaccine and immunotherapeutic candidates is designed to both prevent and treat diseases by harnessing the power of the human immune system. Through their cutting-edge approach to virus-like particles, VBI aims to elicit natural and potent immune responses to combat a range of medical conditions, from highly contagious infectious diseases to fast-growing cancers.
Generated from the website
